ATE226428T1 - Verfahren zur herstellung von pharmazeutischen zusammensetzungen - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen

Info

Publication number
ATE226428T1
ATE226428T1 AT98940460T AT98940460T ATE226428T1 AT E226428 T1 ATE226428 T1 AT E226428T1 AT 98940460 T AT98940460 T AT 98940460T AT 98940460 T AT98940460 T AT 98940460T AT E226428 T1 ATE226428 T1 AT E226428T1
Authority
AT
Austria
Prior art keywords
formulation
pharmacologically
acceptable
pharmaceutical compositions
administration
Prior art date
Application number
AT98940460T
Other languages
English (en)
Inventor
Leburu Seshagiri Rao
Original Assignee
Chauvin Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chauvin Pharmaceuticals Ltd filed Critical Chauvin Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE226428T1 publication Critical patent/ATE226428T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT98940460T 1997-09-03 1998-09-02 Verfahren zur herstellung von pharmazeutischen zusammensetzungen ATE226428T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718568.0A GB9718568D0 (en) 1997-09-03 1997-09-03 Compositions
PCT/GB1998/002637 WO1999011239A1 (en) 1997-09-03 1998-09-02 Method for preparing pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE226428T1 true ATE226428T1 (de) 2002-11-15

Family

ID=10818388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940460T ATE226428T1 (de) 1997-09-03 1998-09-02 Verfahren zur herstellung von pharmazeutischen zusammensetzungen

Country Status (11)

Country Link
US (1) US6379692B1 (de)
EP (1) EP1009380B1 (de)
JP (1) JPH11228386A (de)
AT (1) ATE226428T1 (de)
AU (1) AU741609B2 (de)
CA (1) CA2301325A1 (de)
DE (1) DE69808938T2 (de)
DK (1) DK1009380T3 (de)
ES (1) ES2186207T3 (de)
GB (2) GB9718568D0 (de)
WO (1) WO1999011239A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2396598T3 (es) * 2000-08-25 2013-02-22 Senju Pharmaceutical Co., Ltd. Preparaciones en forma de suspensiones acuosas
AU2001290328A1 (en) * 2000-09-29 2002-04-08 Wakamoto Pharmaceutical Co., Ltd. Eye drops comprising acyclovir suspension
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1499361B1 (de) * 2002-04-19 2012-08-08 Novartis AG Neue biomaterialien, deren herstellung und gebrauch
JP4512700B2 (ja) * 2003-06-02 2010-07-28 トーアエイヨー株式会社 アシクロビル含有水溶液製剤
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CN100475192C (zh) * 2003-06-13 2009-04-08 爱尔康公司 包含两种聚合物的协同组合的眼用组合物
ATE396732T1 (de) * 2004-04-05 2008-06-15 Liomont S A De C V Lab Neue antivirale pharmazeutische zusammensetzung
WO2006031720A2 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
IE51421B1 (en) 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679135B1 (fr) 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
WO1993017664A1 (en) 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
SE9401108D0 (sv) 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
JPH08268892A (ja) 1995-03-30 1996-10-15 Yuuwa Shoji:Kk 水溶液製剤及びその製造方法
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
WO1998043643A1 (fr) 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Preparations d'une solution aqueuse d'acyclovir

Also Published As

Publication number Publication date
AU8878298A (en) 1999-03-22
EP1009380B1 (de) 2002-10-23
EP1009380A1 (de) 2000-06-21
US6379692B1 (en) 2002-04-30
ES2186207T3 (es) 2003-05-01
DE69808938D1 (de) 2002-11-28
GB9818973D0 (en) 1998-10-21
AU741609B2 (en) 2001-12-06
CA2301325A1 (en) 1999-03-11
DK1009380T3 (da) 2003-02-24
GB2328872A (en) 1999-03-10
JPH11228386A (ja) 1999-08-24
GB9718568D0 (en) 1997-11-05
GB2328872B (en) 2002-04-03
WO1999011239A1 (en) 1999-03-11
DE69808938T2 (de) 2003-07-03

Similar Documents

Publication Publication Date Title
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EP1077070A3 (de) Orale Darreichungsform
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
FI950319A (fi) Säädellyn vapautumisnopeuden omaava morfiinivalmiste
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
GR3032234T3 (en) Preparation of microparticles.
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
DE69808938T2 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
DE336200T1 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
CA2284774A1 (en) Theobromine antitussive compositions
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE126052T1 (de) System zur gesteuerten freisetzung von wirkstoffen sowie verfahren zu dessen herstellung.
KR910015297A (ko) 오메프라졸 경구용 약제와 그 제조방법
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties